MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
28.67
+0.97
+3.50%
After Hours: 28.71 +0.04 +0.14% 16:21 12/18 EST
OPEN
27.97
PREV CLOSE
27.70
HIGH
29.19
LOW
27.77
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
34.83
52 WEEK LOW
4.807
MARKET CAP
1.29B
P/E (TTM)
-8.4532
1D
5D
1M
3M
1Y
5Y
1D
MBX Biosciences to Present at J.P. Morgan Healthcare Conference
Reuters · 3d ago
Weekly Report: what happened at MBX last week (1208-1212)?
Weekly Report · 3d ago
MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains
Seeking Alpha · 12/10 17:54
Weekly Report: what happened at MBX last week (1201-1205)?
Weekly Report · 12/08 09:51
Do MBX Biosciences’ Phase 2 Win and Cash Raise Strengthen Its Platform Story or Expose Limits (MBX)?
Simply Wall St · 12/05 17:27
Analysts Conflicted on These Healthcare Names: MBX Biosciences, Inc. (MBX), Praxis Precision Medicines (PRAX) and Iovance Biotherapeutics (IOVA)
TipRanks · 12/05 13:10
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), MBX Biosciences, Inc. (MBX) and Praxis Precision Medicines (PRAX)
TipRanks · 12/05 13:00
MBX Biosciences, Inc. (MBX) Gets a Buy from Guggenheim
TipRanks · 12/05 12:45
More
About MBX
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.